Results 161 to 170 of about 581,749 (280)

Positive patch‐test reactions to para‐phenylenediamine, their clinical relevance and the concept of clinical tolerance [PDF]

, 2001
Yuin‐Chew Chan, See‐Ket Ng, Chee‐Leok Goh   +2 more
openalex   +1 more source

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

Molecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma, Sophia M. Orbach, Kate V. Griffin, Kathryn Kang, Yining Zhang, Rebecca S. Pereles, Ian A. Schrack, Guillermo Escalona, Jacqueline S. Jeruss, Lonnie D. Shea   +9 more
wiley   +1 more source

Predictive factors for Day 7 positive patch test readings at a secondary referral centre. [PDF]

Skin Health Dis, 2022
Tupker RA, Stapper WGC, Kelder JC.
europepmc   +1 more source

Clinical evaluation of antianginal efficacy of nitroglycerin transdermal patch (NT-1) using multi-step treadmill exercise test. Double-blind comparative test between two doses.

, 1987
KAZUSHIGE KATO
openalex   +2 more sources

Screening for acetaldehyde dehydrogenase 2 genotype in alcohol-induced asthma by using the ethanol patch test [PDF]

, 2001
Hiroto Matsuse, Terufumi Shimoda, Chizu Fukushima, Kazuko Mitsuta, Tetsuya Kawano, Shin-ya Tomari, Sachiko Saeki, Yuki Kondoh, Ikuko Machida, Yasushi Obase, Sadahiro Asai, Shigeru Kohno   +11 more
openalex   +1 more source

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

Molecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu, Katherine Eason, Suet‐Feung Chin, Paul A. W. Edwards, Raquel Manzano Garcia, Richard Moulange, Jia Wern Pan, Soo Hwang Teo, Sach Mukherjee, Maurizio Callari, Carlos Caldas, Stephen‐John Sammut, Oscar M. Rueda   +12 more
wiley   +1 more source

A case of bortezomib (Velcade)-induced Stevens-Johnson syndrome confirmed by patch test. [PDF]

Asia Pac Allergy, 2021
Choi GS, Lee HS, Kim HK.
europepmc   +1 more source

Limited Concordance Between “Oakmoss” and Colophony in Clinical Patch Testing [PDF]

, 2001
Wolfgang Uter, Johannes Geier, Axel Schnuch, for the IVDK, Olaf Gefeller   +4 more
openalex   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

Factors Influencing Patients’ Awareness of the Benefits of Patch Testing: A Questionnaire Survey

Siriraj Medical Journal, 2017
Background: Patch testing is a well-established method of diagnosing contact dermatitis; although it is a complex and time consuming process. Objective: To determine the factors influencing patients’ awareness of the benefit of patch testing by using a ...
Waranya Boonchai, Rasthawathana Desomchoke, Pacharee Iamtharachai, Daranee Sornmek   +3 more
doaj